Download pdf
Exploring the Potential of Stem Cells to Enhance Conventional Cancer Therapies
- 1 Hwa Chong International School 663 Bukit Timah Road, Singapore- 269783
* Author to whom correspondence should be addressed.
Abstract
Stem cell-based therapies are emerging as promising adjuncts to conventional cancer treatments, offering innovative strategies to target cancer cells and enhance patient recovery. This paper explores the potential of stem cells, particularly mesenchymal stem cells (MSCs) and human umbilical cord mesenchymal stem cells (HUCMCs), to improve cancer treatment outcomes through their regenerative and differentiation capabilities. MSCs exhibit significant promise due to their ability to inhibit tumor growth, support tissue regeneration, and modulate immune responses. Their unique features, including targeted homing to tumor sites and the secretion of bioactive molecules, present novel approaches to overcoming the limitations of traditional therapies. Despite these advancements, challenges such as immune rejection and tumorigenicity must be addressed. Current strategies to mitigate these issues involve immunosuppressive drugs, genetic engineering, and advanced technologies like CRISPR-Cas9. However, the reviewed studies often involve small sample sizes or remain in the laboratory phase, limiting the generalizability of findings. Future research should focus on larger-scale clinical trials to validate the effectiveness and safety of stem cell therapies, aiming to refine these treatments and integrate them into clinical practice.
Keywords
Stem Cell Therapy, Mesenchymal Stem Cells (MSCs), Human Umbilical Cord Mesenchymal Stem Cells (HUCMCs), Cancer Treatment, Tumorigenicity.
[1]. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
[2]. Venitt, S. (1996). Mechanisms of Spontaneous Human Cancers. Environmental Health Perspectives, 104(Suppl 3), 633-637. https://www.jstor.org/stable/3432836
[3]. National Cancer Institute. (2021). Understanding Cancer. Retrieved from https://www.cancer.gov/about-cancer/understanding
[4]. American Cancer Society. (2021). What Is Cancer? Retrieved from https://www.cancer.org/cancer/cancer-basics/what-is-cancer.html
[5]. Sheng, G. (2015). The Developmental Basis of Mesenchymal Stem/Stromal Cells (MSCs). BMC Developmental Biology, 15, 1-8.
[6]. Szydlak, R. (2021). Biological, Chemical, and Mechanical Factors Regulating Migration and Homing of Mesenchymal Stem Cells. World Journal of Stem Cells, 13(6), 619.
[7]. Lotfy, A., AboQuella, N. M., & Wang, H. (2023). Mesenchymal Stromal/Stem Cell (MSC)-Derived Exosomes in Clinical Trials. Stem Cell Research & Therapy, 14(1), 66.
[8]. Faramin Lashkarian, M., Hashemipour, N., Niaraki, N., Soghala, S., Moradi, A., Sarhangi, S., ... & Aghaei-Zarch, S. M. (2023). MicroRNA-122 in Human Cancers: From Mechanistic to Clinical Perspectives. Cancer Cell International, 23(1), 29.
[9]. Jiang, J., Li, J., Zhou, X., Zhao, X., Huang, B., & Qin, Y. (2022). Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer. Frontiers in Oncology, 12, 864980.
Cite this article
Meng,H. (2024). Exploring the Potential of Stem Cells to Enhance Conventional Cancer Therapies. Theoretical and Natural Science,63,9-14.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).